Atea Pharmaceuticals, Inc. Variable Lease, Cost
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-05
- Atea Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2021-12-31 was $13.00K.
- Atea Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2021-09-30 was $4.00K.
- Atea Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2021-06-30 was $11.00K.
- Atea Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2021-03-31 was $6.00K.
- Atea Pharmaceuticals, Inc. variable lease, cost for fiscal 2025 was $62.00K, a 10.71% increase from fiscal 2024.
- Atea Pharmaceuticals, Inc. variable lease, cost for fiscal 2024 was $56.00K, a 40.00% increase from fiscal 2023.
- Atea Pharmaceuticals, Inc. variable lease, cost for fiscal 2023 was $40.00K, a 48.72% decline from fiscal 2022.
- Atea Pharmaceuticals, Inc. variable lease, cost for fiscal 2022 was $78.00K, a 110.81% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $62.00K 10-K · filed 2026-03-05 | |||
| 2024-12-31 | $56.00K 10-K · filed 2026-03-05 | |||
| 2023-12-31 | $40.00K 10-K · filed 2025-03-06 | |||
| 2022-12-31 | $78.00K 10-K · filed 2024-02-28 | |||
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $17.00K derived: sum of 2 quarters · filed 2023-02-28 | $28.00K derived: sum of 3 quarters · filed 2023-02-28 | $37.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $4.00K 10-Q · filed 2021-11-12 | $15.00K derived: sum of 2 quarters · filed 2021-11-12 | $24.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $11.00K 10-Q · filed 2021-08-12 | $20.00K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $6.00K 10-Q · filed 2021-05-13 |